VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2001

Primary Completion Date

March 31, 2002

Conditions
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

ziv-aflibercept

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Regeneron Pharmaceuticals

INDUSTRY

NCT00036946 - VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma | Biotech Hunter | Biotech Hunter